Navigation Links
DOs and DON’Ts of Study Start-Up: Best Practices to Improve Efficiency and Meet/Exceed Timelines, New Life Science Webinar Hosted by Xtalks
Date:7/11/2013

Toronto, Canada (PRWEB) July 11, 2013

Efficient and effective study start-up is crucial to the success of every study. From country and site selection to resource oversight, there are challenges embedded in every investigation that can impact study start and timely delivery.

In order to address these challenges and set the path for success, several questions should be considered:

  •     How do you select countries and sites that will improve your chances of finding and retaining the right patients for your study?
  •     Can you cost-effectively implement a proactive patient strategy, and avoid the need for rescue programs?
  •     How can you leverage data and planning techniques to minimize management oversight while optimizing efficiencies by matching studies, sites, and patients impacting patient health?

In this webinar, experts from Quintiles will discuss best practices for applying quantitative and qualitative information to develop study strategies, from feasibility through patient recruitment. The speakers will highlight how an empowered delivery team can enhance efficiency, minimize the need for extensive oversight, and deliver greater overall accountability for meeting your study goals.

Through case examples, we will show how the appropriate tools and insight from data and strategies are applied in a real-world setting to deliver tangible benefits to clinical development stakeholders.

To learn more about the event, visit:
http://xtalks.com/DOs-and-DONTs-of-Study-Start-Up.ashx

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year, thousands of industry practitioners turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com/ContactUs.ashx

Contact:
Karen Lim (416) 977-6555 ext 227
clientservices(at)xtalks(dot)com

Read the full story at http://www.prweb.com/releases/2013/7/prweb10912646.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Study Scavenger and JALR.org Announce Alliance Utilizing Smart Phone Capabilities to Bring Clinical Trials to Motivated Subjects
2. New Approaches in Immunogenicity Assessment Using the New SQiDlite™ System: Case Study Analysis, New Life Science Webinar Hosted by Xtalks
3. New Study Reveals that PEEK Polymer Spinal Cage Is Superior to Titanium in Surgical Treatment of Multilevel Cervical Spondylotic Myelopathy
4. Americord Applauds Study on Stem Cell Therapy for Congenital Heart Defects
5. Study Data Tabulation Model in Real Time, New Webinar Hosted by Xtalks
6. RegeneCure Starts Clinical Study Using Polymeric Bone Stimulating Membrane for Dental Implants
7. Lilly and Incyte Announce Baricitinib Efficacy and Safety Data from the Open-Label, Long-Term Extension of the Phase 2b JADA Study in Patients with Rheumatoid Arthritis
8. Are Root Canals Headed for Obscurity? Stem Cell Study Indicates Maybe So
9. Adult Acne Treatment Explains a New Upcoming Study that may Change the Acne Treatment Industry
10. Ambit Announces Presentation of Results from Phase 2 ACE Study of Quizartinib in Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML) at the Annual Meeting of the American Society of Clinical Oncology
11. Endpoint Based Protocol Development: A Central Laboratory Perspective + Microbiology Case Study, New Life Science Webinar Hosted by Xtalks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2017)... ... , ... Mitotech S.A, a Luxembourg based clinical stage biotechnology company, announced positive ... a rare devastating genetic disease that leads to a sudden and rapid loss of ... patients carrying 11778, 14484 and 3460 mutations and having experienced the onset of symptoms ...
(Date:4/27/2017)... ... April 27, 2017 , ... ... and a name change to Fluence Analytics. , Fluence Analytics provides ... polymer and biopharmaceutical manufacturing processes and R&D applications. The company’s patented technologies ...
(Date:4/26/2017)... ... April 26, 2017 , ... Looking for ... and cooking events company, offers one-of-a-kind gifts, ranging from gourmet cooking experiences to ... cuisine, and guests leave inspired with new cooking tips and techniques, thanks to ...
(Date:4/26/2017)... ... 26, 2017 , ... NextSteps 2017, NetDimensions’ annual global user ... this May on the following dates: , ?    London, UK from May 10-11, ?    New ... and Performance Institute will be the opening keynote speaker at the NextSteps ...
Breaking Biology Technology:
(Date:4/11/2017)... Fla. , April 11, 2017 ... and secure authentication solutions, today announced that it ... Intelligence Advanced Research Projects Activity (IARPA) to develop ... Thor program. "Innovation has been a ... IARPA,s Thor program will allow us to innovate ...
(Date:4/11/2017)... NXT-ID, Inc. (NASDAQ:   NXTD ) ("NXT-ID" or ... independent Directors Mr. Robin D. Richards and Mr. ... the company,s corporate governance and expertise. ... Gino Pereira , Chief Executive Officer said," ... and benefiting from their considerable expertise as we move forward ...
(Date:4/5/2017)... NEW YORK , April 5, 2017 ... security, is announcing that the server component of the ... is known for providing the end-to-end security architecture that ... customers. HYPR has already secured over 15 ... system makers including manufacturers of connected home product suites ...
Breaking Biology News(10 mins):